Introduction
The prevalence of chronic kidney disease (CKD) is approximately 15 % in developed countries, making it a major worldwide health concern. Reduced kidney function lasting three months or longer is referred to as chronic kidney disease (CKD), which includes a range of illnesses from minor kidney impairment to end-stage kidney disease. It is based on the estimated glomerular filtration rate (eGFR), which measures the amount of waste the kidneys clear each minute. The primary cause of chronic kidney disease (CKD) is diabetes, which is also the leading cause of CKD globally. Alternatively, a multisystem condition associated with comorbidities may be the cause of CKD. Neurological problems in CKD are very common, regardless of the reason.
Damage can happen to the nervous system at any level, from peripheral nervous system (PNS) illnesses like autonomic and peripheral neuropathies to central nervous system (CNS) disorders, including stroke, cognitive impairment, and encephalopathy. The existence of these problems significantly impacts patient morbidity and death. Therefore, the clinical treatment of neurological issues in CKD requires understanding the underlying physiological and pathological abnormalities. Early detection and treatment of these disorders may reduce the impact of neurological implications in later stages of chronic renal disease, even if these consequences often appear clinically in end-stage disease.
What Are the Neurological Complications of Chronic Kidney Disease?
Persistent Signs of a Changed Mental State:
Stroke, cognitive impairment, and dementia are common causes of long-term changes in mental state in people with chronic kidney disease (CKD). These conditions share a number of pathophysiological processes because they are symptoms of persistent CNS (central nervous system) damage.
The pathophysiological understanding of CKD, CNS damage is probably complex. Nonetheless, the suggested pathways can be separated into two newer theories: neurodegenerative and vascular.
-
Vascular Theory: In populations with chronic kidney disease (CKD), traditional cardiovascular risk factors such as hypercholesterolemia, smoking, diabetes, high blood pressure, and excessive cholesterol are quite common. These risk factors are commonly believed to be this population's primary causes of vascular damage. Non-traditional risk factors common in chronic kidney disease (CKD), such as metabolic abnormalities, particularly those related to calcium and phosphate, hyperhomocysteinemia (once the levels surpass 15 micromol/L. Homocysteine metabolism is disrupted when levels of the metabolic product exceed standard ranges), hypercoagulable (is the blood's heightened propensity to thrombose) states, inflammation, and oxidative stress, can also influence and/or accelerate vascular damage. These factors are believed to worsen endothelial (cells lining the arterial wall) function and lead to atherosclerosis (the accumulation of chemicals, fats, and cholesterol within and on the walls of the arteries). Accelerated vascular calcification results from failure of phosphate excretion, which raises serum phosphate, calcium-phosphate product, and parathyroid hormone (PTH).
-
Hypothesis of Neurodegeneration: The likelihood that uremic toxins will cause CNS damage, either directly or indirectly, has long been acknowledged. As previously indicated, systemic inflammation, endothelial dysfunction, and atherosclerosis are among the indirect impacts of the uremic milieu. Numerous uremic toxins have been studied for their potential to cause direct neurotoxicity in the setting of chronic kidney disease. Numerous substances, including uric acid, indoxyl sulfate, p-cresyl sulfate, interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α), have been linked to cerebrorenal interactions. Recent research has shown that irrespective of age, race, education level, or medical comorbidities, higher serum levels of cystatin-C are linked to poorer cognitive scores. Although more long-term research is needed, it is hypothesized that cystatin-C may contribute to neurodegeneration by forming amyloid plaques.
Stroke:
An official definition of a stroke is "death of brain, spinal cord, or retinal cells due to ischemia, based on neuropathological, neuroimaging, and/or clinical evidence of irreversible damage." Stroke is more common in long-term dialysis users (17%) than in non-dialysis CKD patients (10%) and the general population (4%). Furthermore, dialysis patients had poorer post-stroke outcomes than non-CKD patients, with fatality rates three to five times greater.
Dementia and Cognitive Impairment:
A new deficiency in two or more cognitive function domains is called cognitive impairment. Cognitive impairment may not impede day-to-day functioning in its lesser forms. Dementia, on the other hand, is characterized by a continuous decline in cognitive ability and a significant behavioral disruption that interferes with independence and day-to-day functioning. A separate risk factor for dementia and increasing cognitive decline is chronic kidney disease (CKD). Dementia is a significant clinical consequence because it can lead to poor medical adherence and health literacy, and it is a strong indicator of mortality for dialysis patients. Even though cognitive impairment is acknowledged as a frequent CKD consequence, nothing is known about it.
Delirium and Encephalopathy
When discussing the toxic metabolic encephalopathy that develops in chronic kidney disease (CKD), the terms encephalopathy and delirium are commonly used interchangeably. While alterations in electroencephalography (EEG) can corroborate encephalopathy, both terms allude to an immediate generalized modification of brain function or structure brought on by a toxic or metabolic imbalance.
A wide range of symptoms, including delirium, coma, and moderate sensory clouding, are associated with uremic encephalopathy eighteen. It might be challenging to diagnose uremic encephalopathy early on since symptoms, including weariness, apathy, irritability, and poor focus, can have a subtle onset. Generalized or localized motor abnormalities, such as tremors, fasciculations, asterixis, and seizures, can coexist with mental status changes. Seizures, hallucinations, delirium, confusion, disorientation, and coma are among the more severe later symptoms.
What Are the Physical Incapacity Related to Chronic Kidney Disease (CKD)?
Physical impairment affects independence and daily life activities significantly and is a prevalent issue among CKD patients. A number of PNS illnesses may appear as physical disability.
Peripheral Neuropathy:
About 90% of dialysis patients get peripheral neuropathy, commonly referred to as uremia neuropathy, which is the most frequent neurological consequence of CKD. Symptoms that are usually functionally incapacitating include pain, weakness, and loss of sensation. Another important factor in ulceration and amputation is neuropathy.
Autonomic Neuropathy:
A condition known as autonomic dysfunction occurs when there is a disruption in the autonomic outflow, leading to an increase in sympathetic activity and a reduction in parasympathetic activity. Autonomic dysfunction is a common condition in chronic kidney disease (CKD), affecting over 50 % of patients receiving hemodialysis. Since CKD patients typically have diabetes, vascular disease, and hypertension, it is difficult to determine a direct relationship between autonomic dysfunction and these disorders. Recent research, however, indicates that the degree of sympathetic overdrive is correlated with the severity of renal failure and that autonomic dysfunction may be identifiable in the early stages of chronic kidney disease.
Myopathy:
Myopathy affects around half of the dialysis patients with CKD. A characteristic of myopathy is proximal muscular weakness in the lower limb muscles. Because their endurance and exercise capacity are diminished, patients with myopathy have much fewer functional options, which raises their risk of death and morbidity.
Conclusion
The distinction between acute and chronic central nervous system disorders can be made in presentations of altered mental status. Long-term risk management techniques are necessary to optimize outcomes for individuals with chronic kidney disease (CKD), including stroke, cognitive decline, and dementia. Numerous metabolic and pharmaceutical exposures common in chronic kidney disease (CKD) can produce acute encephalopathies, which need to be treated quickly to prevent worsening to the point of seizures or coma. In patients with chronic kidney disease (CKD), peripheral neuropathy, autonomic neuropathy, and myopathy are the most common causes of physical disability. Although they are probably present at far earlier stages of CKD, PNS and CNS problems are most noticeable at end-stage disease.
